CKD-AKI Flashcards
Definition of AKI
- Abrupt decline in GFR occurring over hours to days/weeks
- Associated with accumulation of waste products (urea and creatinine)
- Inability to maintain and regulate fluid, electrolyte and acid-base balance
- Increase in SCr by ≥ 26.5 μmol/L within 48 h, or
- Increase in SCr to ≥ 1.5x baseline, within 7 days, or
- Urine vol < 0.5 ml/kg/h for ≥ 6 h
risk factors for AKI
- > 60yo
- Female
- Acute infection
- Pre-existing chronic respiratory or CVS disease
- Dehydration/volume depletion
- Pre-existing CKD -> AoCKD
levels of urine output
normal, non oliguria, oliguria, anuria
- Normal urine output ≥ 1200 ml/day
- Non-oliguria: Urine output > 500 ml/day
- Oliguria: Urine output < 500 ml/day
- Anuria: Urine output < 50 ml/day
Clinical presentation of AKI
- Reduced urine output
- Peripheral edema (due to fluid accumulation)
- Flank pain
- Lab abnormalities:
a. Elevated SCr, BUN, K
b. Metabolic acidosis (Low CO2)
c. Urinalysis -> presence of casts, cells, crystals, WBC, RBC protein or abnormal specific gravity, fractional excretion of Na, urine osmolality
types of AKI
- pre renal (from decreased prefusion to kidneys)
- intrinsic (from structural damage of kidneys)
- post renal (obstruction of urine flow after kidneys)
Causes of pre renal AKI
abnormality and what causes the abnormalities
- volume depletion –> hemorrage, GI losses
- reduced cardiac output –> CHF/MI
- renal hypoperfusion –> thrombosis, emboli, drug induced (!!)
result in dec afferent arteriole pressure
diagnosis and evaluation of pre renal AKI
clinical presentation and urine lab abnormalities
- Pt history (GI loss, diuresis)
- Physical Exam (orthostatic hypotension, tachycardia, poor skin turgor)
- Central venous pressure
- pt will have highly concentrated urine, low in Na, high SG (specific gravity), oliguria
what drugs can cause pre renal AKI
- NSAIDs
- ACEi/ARB
PG inhibitor prevents afferent arteriole from dilating –> prevents increased RBF
ACEi prevents constriction of efferenct arteriole due to Ang II –> decrease pressure
management of pre renal AKI
- no specific treatment
- Reverse of etiologic factors (treat pre-renal causes)
- Use of vasopressors with fluids in pts with vasomotor shock
- Supportive care
types of intrinsic AKI
- Acute tubular necrosis (need to know)
- Acute interstitial nephritis (need to know)
- Glomerular damage
- vascular damage
causes of ATN
drugs (radiocontrast, aminoglycoside, amphoterin B) / injury
- Injury causes tubule epithelial cell necrosis/apoptosis; hypoxia and inflammatory response; damaged tubular cells sloughed off
- Result: Loss of ability to concentrate urine, defective sodium reabsorption and reduction in GFR
4 phases of ATN
- Initiating – ischemia/injury
- Oliguric – cant excrete waste
- Diuretic – increase urine, renal blood flow and GFR (reabsorb Na and concentrate urea)
- Recovery – return to normal
- Oliguria occurs in 70-80% of patients with ATN
- Volume is lower than necessary to excrete body waste products
- Anuria is less common
- Duration of oliguric phase is 1-2 weeks
- The longer the duration, the greater the risk of complications and the worse the outcome and prognosis
management of ATN oliguric phase
- Diuretics (mostly loop like furosemide)
- CCB
- Water, Na, K, P acid-base balance
- Nutrition, drug dosage adjustment, dialysis
- CCB– Reverse renovascular constriction, increase renal blood flow, GFR
- Role is to increase urine output, fluid management
- Diuretic resistance is common –needs aggressive Na restriction, Combination diuretic therapy, IV dosing or continuous infusion of loop diuretics
- Avoid overdiuresis or use of diuretics in pre-renal AKI
how does radiocontrast cause ATN?
- Mechanism: alter renal hemodynamics, cause renal ischemia, direct toxicity
- Progressive increase in SCr within 24-48h after contrast administration, usually peaks within 5 days
Increased risk for death or prolonged hospitalization
risk factors for radiocontrast induced ATN
- preexisting CKD, DM, HTN, CHF, metabolic syndrome, hyperuricemia
- age
- volume depletion
- concomitant administration of nephrotoxins, use high volume/ionic high osmolar contrast media
- nephtoxins: discontinue NSAIDs, AG, ampho B, high dose loop diuretics (prevent over diuresis), antivirals, metformin (prevent lactic acidosis)
- use isotonic/non ionic/low osmolar contrast